Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure

NCT01394978 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT01394978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01394978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
February 29, 2016
Enrollment
444 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung tumor